RI
BIOA

RTW Investments’s BioAge Labs BIOA Stock Holding History

RTW Investments’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-786,353
Closed -$2.96M – 78
2025
Q1 		$2.96M Hold
786,353
– – 0.05% 62
2024
Q4 		$4.55M Hold
786,353
– – 0.07% 62
2024
Q3 		$16.4M Buy
+786,353
New +$15.8M 0.24% 49

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return

RTW Investments's BIOA Position: Q2 2025 in Review

RTW Investments sold out of BioAge Labs (BIOA) in Q2 2025, closing a stake of 786,353 shares — an estimated $2.96M sold.

RTW Investments first reported a position in BIOA in Q3 2024 and held it in 3 quarters. The position peaked at $16.4M in Q3 2024. 83 funds tracked by Wall St. Rank hold BIOA as of Q2 2025.

  • RTW Investments reported no remaining BioAge Labs position as of Q2 2025 after selling out during the quarter.
  • RTW Investments sold 786,353 BioAge Labs shares in Q2 2025, an estimated $2.96M.
  • RTW Investments first reported a position in BioAge Labs in Q3 2024 and held it in 3 quarters.
  • RTW Investments's BioAge Labs position peaked at $16.4M in Q3 2024.
  • 83 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2025.

Based on RTW Investments's 13F filing for Q2 2025, filed 14 Aug 2025.